Diagnos Laboratorium Utama Tbk. vs Indo Straits Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Indo Straits Tbk. trades at Rp268 (market cap 147.44B, 16K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 2.1× Indo Straits Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 16K). Which is the better fit depends on your goals.
| DGNS | PTIS | |
|---|---|---|
Market Cap | 310.75B | 147.44B |
Volume | 963.6K | 16K |
Lot | 9.64K | 160 |
Turnover | 217.67M | 4.22M |
Average Price | 225.89 | 263.75 |
Value | 217.67M | 4.22M |
Indicative Equilibrium Price | 226 | 268 |
Indicative Equilibrium Volume | 1K | 2 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Indo Straits (the "Company") was established based on Notarial Deed No 319 of Ridwan SH, dated January 21, 1985. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 4 of Leolin Jayanti SH dated March 8, 2011 pertaining of change composition of the Company's board of Commissioners and Boards of Directors, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity.
Read more on PTIS →